180 related articles for article (PubMed ID: 38539508)
21. Heterogeneity of the Tumor Microenvironment Across Molecular Subtypes of Breast Cancer.
Kashyap D; Bal A; Irinike S; Khare S; Bhattacharya S; Das A; Singh G
Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):533-543. PubMed ID: 37358863
[TBL] [Abstract][Full Text] [Related]
22. Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer.
Ding R; Wang Y; Fan J; Tian Z; Wang S; Qin X; Su W; Wang Y
Front Oncol; 2023; 13():1108472. PubMed ID: 37377907
[TBL] [Abstract][Full Text] [Related]
23. Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks.
Zhou S; Huang YE; Liu H; Zhou X; Yuan M; Hou F; Wang L; Jiang W
Mol Ther Nucleic Acids; 2021 Mar; 23():682-690. PubMed ID: 33575114
[TBL] [Abstract][Full Text] [Related]
24. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
25. Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer.
Yi J; Zhong W; Wu H; Feng J; Zouxu X; Huang X; Li S; Shuang Z
Front Oncol; 2021; 11():746058. PubMed ID: 34745969
[TBL] [Abstract][Full Text] [Related]
26. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer.
Liu Y; Fang Y; Bao L; Wu F; Wang S; Hao S
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291687
[TBL] [Abstract][Full Text] [Related]
27. Analysis of single-cell RNA-sequencing data identifies a hypoxic tumor subpopulation associated with poor prognosis in triple-negative breast cancer.
Shi Y; Huang X; Du Z; Tan J
Math Biosci Eng; 2022 Apr; 19(6):5793-5812. PubMed ID: 35603379
[TBL] [Abstract][Full Text] [Related]
28. Development of a CD8
Dai YW; Wang WM; Zhou X
Heliyon; 2023 Sep; 9(9):e19798. PubMed ID: 37810147
[TBL] [Abstract][Full Text] [Related]
29. Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
Liu X; Bai M; Li H; Ye P; Duan X; Wu C; Huang Z; Lu S; Zhang J; Zhao Z; Guo F; You R; Qin W; Wang W; Han A; Shen L; Wang Y; Zhao Z; Luo H; Wu J
Front Immunol; 2022; 13():965342. PubMed ID: 36389835
[TBL] [Abstract][Full Text] [Related]
30. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC.
Wu X; Lu W; Zhang W; Zhang D; Mei H; Zhang M; Cui Y; Zhuo Z
Aging (Albany NY); 2023 Nov; 15(21):12674-12697. PubMed ID: 37963845
[TBL] [Abstract][Full Text] [Related]
32. Delving into the Heterogeneity of Different Breast Cancer Subtypes and the Prognostic Models Utilizing scRNA-Seq and Bulk RNA-Seq.
Xu J; Qin S; Yi Y; Gao H; Liu X; Ma F; Guan M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077333
[TBL] [Abstract][Full Text] [Related]
33. Mapping the Tumor Microenvironment in TNBC and Deep Exploration for M1 Macrophages-Associated Prognostic Genes.
Xu B; Sun H; Song X; Liu Q; Jin W
Front Immunol; 2022; 13():923481. PubMed ID: 35844580
[TBL] [Abstract][Full Text] [Related]
34. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
Qattan A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
[TBL] [Abstract][Full Text] [Related]
35. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
[TBL] [Abstract][Full Text] [Related]
36. Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio.
Liu J; Deng Y; Liu Z; Li X; Zhang M; Yu X; Liu T; Chen K; Li Z
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512096
[No Abstract] [Full Text] [Related]
37. Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data.
Xing K; Zhang B; Wang Z; Zhang Y; Chai T; Geng J; Qin X; Chen XS; Zhang X; Xu C
Cells; 2023 Jan; 12(3):. PubMed ID: 36766710
[TBL] [Abstract][Full Text] [Related]
38. Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes.
Vishnubalaji R; Alajez NM
Cells; 2023 Apr; 12(8):. PubMed ID: 37190091
[TBL] [Abstract][Full Text] [Related]
39. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
[TBL] [Abstract][Full Text] [Related]
40. Targeting tumor-stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model.
Hachey SJ; Hatch CJ; Gaebler D; Mocherla A; Nee K; Kessenbrock K; Hughes CCW
Breast Cancer Res; 2024 Jan; 26(1):5. PubMed ID: 38183074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
